Petrucci, Giovanna
 Distribuzione geografica
Continente #
EU - Europa 1.688
NA - Nord America 1.391
AS - Asia 741
SA - Sud America 134
AF - Africa 16
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.985
Nazione #
US - Stati Uniti d'America 1.365
DE - Germania 505
IT - Italia 322
SE - Svezia 294
CN - Cina 273
SG - Singapore 270
UA - Ucraina 131
BR - Brasile 123
FR - Francia 93
IE - Irlanda 80
GB - Regno Unito 78
ID - Indonesia 53
IN - India 46
RU - Federazione Russa 46
FI - Finlandia 41
TR - Turchia 36
BE - Belgio 25
CZ - Repubblica Ceca 21
CA - Canada 19
KR - Corea 19
AT - Austria 11
AU - Australia 11
IR - Iran 11
NL - Olanda 10
HK - Hong Kong 9
CI - Costa d'Avorio 8
ES - Italia 5
PH - Filippine 5
AR - Argentina 4
CH - Svizzera 4
LV - Lettonia 4
MX - Messico 4
NO - Norvegia 4
BO - Bolivia 3
EG - Egitto 3
IQ - Iraq 3
LT - Lituania 3
NG - Nigeria 3
PK - Pakistan 3
PL - Polonia 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DK - Danimarca 2
EC - Ecuador 2
EU - Europa 2
IL - Israele 2
SA - Arabia Saudita 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HU - Ungheria 1
JM - Giamaica 1
JP - Giappone 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 3.985
Città #
Chandler 289
Ashburn 149
Singapore 141
Dublin 76
San Mateo 74
Jacksonville 68
Rome 63
Nanjing 56
Cattolica 55
Milan 54
Ann Arbor 53
Jakarta 53
Wilmington 46
Moscow 34
Dearborn 29
Boston 27
Woodbridge 26
Nürnberg 25
Princeton 24
Frankfurt am Main 21
Munich 21
New York 21
Bremen 20
Brno 20
Brussels 20
Hounslow 20
Nanchang 20
Houston 19
Los Angeles 19
Izmir 18
Bareggio 17
Hefei 17
Lawrence 17
Redwood City 17
Seoul 15
Fairfield 14
Helsinki 14
Beijing 13
Redmond 13
Shenyang 13
Hebei 11
Kunming 11
Seattle 11
Tianjin 11
Verona 11
Hyderabad 10
Busto Arsizio 9
Chicago 9
Hong Kong 9
Lancaster 9
London 9
Abidjan 8
Augusta 8
Mountain View 8
Vienna 8
Zhengzhou 8
Bursa 7
Guangzhou 7
Hangzhou 7
Jinan 7
São Paulo 7
Düsseldorf 6
Marseille 6
Shanghai 6
Andover 5
Belo Horizonte 5
Boardman 5
Catania 5
Chieti 5
Leawood 5
Nuremberg 5
Ottawa 5
Paris 5
The Dalles 5
Charlotte 4
North York 4
Pune 4
Quezon City 4
Riga 4
Santo André 4
Toronto 4
Washington 4
Ankara 3
Avon 3
Bexley 3
Changchun 3
Detroit 3
Falkenstein 3
Falls Church 3
Gent 3
Istanbul 3
Kish 3
Lagos 3
Lanzhou 3
Lappeenranta 3
Lauterbourg 3
Padova 3
Prineville 3
Roubaix 3
Sacramento 3
Totale 2.050
Nome #
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 275
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 152
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 148
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 144
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 136
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 134
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 129
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 127
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 122
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 117
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 117
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 115
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 114
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 103
Aspirin, stroke and drug-drug interactions 87
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 85
Preoperative psychological characteristics affecting mid-term outcome after bariatric surgery: a follow-up study 84
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 80
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 77
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 77
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 75
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation. 75
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 74
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 72
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 70
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 67
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. 63
Pathophysiology of Thrombosis in Peripheral Artery Disease 57
Mesenchymal differentiation of glioblastoma stem cells 56
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 56
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 55
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 55
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 55
influence of local environment on the differentiation of neuronal stem cells engrafted onto the injured spinal cord 52
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 52
Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms. 51
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 50
Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of response 45
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 44
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 44
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 43
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord 40
Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation 39
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 37
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 35
Mesenchymal differentiation of glioblastoma stem cells 35
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 33
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 33
Pathophysiology of Thrombosis in Peripheral Artery Disease 32
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 31
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 27
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 26
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 23
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 18
Prolonged fasting promotes systemic inflammation and platelet activation in humans: a medically supervised, water-only fasting and refeeding study 15
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 8
Totale 4.066
Categoria #
all - tutte 18.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020101 0 0 0 0 0 0 0 0 0 0 72 29
2020/2021332 17 64 9 25 38 13 35 11 35 13 51 21
2021/2022390 40 18 5 24 30 10 10 85 14 19 59 76
2022/2023808 105 116 69 118 61 89 26 70 100 18 22 14
2023/2024507 15 108 19 58 44 46 31 16 15 25 51 79
2024/2025874 28 24 68 49 103 30 17 81 136 88 250 0
Totale 4.066